Sellas Life Sciences Group Inc banner

Wall St Price Targets

RXK3 Price Forecast
Based on 3 analysts

-56% Downside
from €10.05 today

Sellas Life Sciences Group Inc (RXK3)’s 12-month stock price forecast through October 2027 has a consensus target of €4.44, implying 56% downside. The forecast is based on price targets from 3 Wall Street analysts.

RXK3 Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for RXK3 yet.

Sellas Life Sciences Group Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RXK3's stock price target?
Price Target
4.44 EUR

According to Wall Street analysts, the average 1-year price target for RXK3 is 4.44 EUR with a low forecast of 4.06 EUR and a high forecast of 4.92 EUR.

Back to Top